source
- FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer DrugsThe U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.fda press · 2mo ago↗ source
- #ASCO26: Bristol Myers details Phase 3 trial win for Pomalyst successorBristol Myers Squibb’s next-gen multiple myeloma drug cut the risk of disease progression or death for certain patients by 52% when added on top of a combination treatment regimen. The New Jersey p…Endpoints · 2mo ago↗ source
- Pfizer, Innovent strike $10B cancer drug dealInvolving up to 12 antibody drugs, the alliance is the latest broad partnership between Chinese biotech and a multinational pharmaceutical company.